(Q33628788)

28 July 2017

title

Phase III, randomized, double-blind, placebo-controlled evaluation of pregabalin for alleviating hot flashes, N07C1 (English)

1 reference

28 July 2017

0 references

Charles L Loprinzi

1

1 reference

28 July 2017

Rui Qin

2

1 reference

28 July 2017

Ernie P Balcueva

3

1 reference

28 July 2017

Kathleen A Flynn

4

1 reference

28 July 2017

Kendrith M Rowland

5

1 reference

28 July 2017

David L Graham

6

1 reference

28 July 2017

Nancy K Erwin

7

1 reference

28 July 2017

Shaker R Dakhil

8

1 reference

28 July 2017

Donald J Jurgens

9

1 reference

28 July 2017

Kelli N Burger

10

1 reference

28 July 2017

language of work or name

English

0 references

publication date

9 November 2009

1 reference

28 July 2017

number of pages

7

1 reference

Journal of Clinical Oncology

inferred from page(s)

published in

1 reference

28 July 2017

volume

28

1 reference

28 July 2017

issue

4

1 reference

28 July 2017

page(s)

641-647

1 reference

Comparison of subjective and objective hot flash measures over time among breast cancer survivors initiating aromatase inhibitor therapy

28 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2815998

Newer antidepressants and gabapentin for hot flashes: an individual patient pooled analysis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2815998

A phase III randomized, double-blind, placebo-controlled trial of gabapentin in the management of hot flashes in men (N00CB).

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2815998

Sertraline to treat hot flashes: a randomized controlled, double-blind, crossover trial in a general population

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2815998

Randomized, double-blind, placebo-controlled, crossover study of sertraline (Zoloft) for the treatment of hot flashes in women with early stage breast cancer taking tamoxifen

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2815998

Gabapentin for hot flashes in 420 women with breast cancer: a randomised double-blind placebo-controlled trial

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2815998

Paroxetine controlled release in the treatment of menopausal hot flashes: a randomized controlled trial

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2815998

Gabapentin's effects on hot flashes in postmenopausal women: a randomized controlled trial

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2815998

21 June 2018

The menopausal syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2815998

On hot flash mechanism, measurement, and treatment.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2815998

Efficacy and tolerability of desvenlafaxine succinate treatment for menopausal vasomotor symptoms: a randomized controlled trial

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2815998

Gabapentin for the treatment of menopausal hot flashes: a randomized controlled trial

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2815998

Ineffectiveness of sertraline for treatment of menopausal hot flushes: a randomized controlled trial

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2815998

Phase III comparison of depomedroxyprogesterone acetate to venlafaxine for managing hot flashes: North Central Cancer Treatment Group Trial N99C7.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2815998

Paroxetine is an effective treatment for hot flashes: results from a prospective randomized clinical trial

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2815998

Pilot evaluation of gabapentin for treating hot flashes

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2815998

Phase III evaluation of fluoxetine for treatment of hot flashes

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2815998

Methodologic lessons learned from hot flash studies

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2815998

Menopausal symptoms in breast cancer survivors.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2815998

Megestrol Acetate for the Prevention of Hot Flashes

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2815998

Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial

30 October 2018

1 reference

12 December 2020

Prospective evaluation of vitamin E for hot flashes in breast cancer survivors

1 reference

12 December 2020

Transdermal clonidine for ameliorating tamoxifen-induced hot flashes

1 reference

12 December 2020

Accuracy of subjective hot flush reports compared with continuous sternal skin conductance monitoring

1 reference

12 December 2020

Gabapentin, estrogen, and placebo for treating hot flushes: a randomized controlled trial

1 reference

12 December 2020

Phase III double-blind, randomized, placebo-controlled crossover trial of black cohosh in the management of hot flashes: NCCTG Trial N01CC1

1 reference

12 December 2020

The Hot Flash Related Daily Interference Scale: a tool for assessing the impact of hot flashes on quality of life following breast cancer

1 reference

12 December 2020

Laboratory and ambulatory monitoring of menopausal hot flashes

1 reference

12 December 2020

Gadgets for measuring hot flashes: have they become the gold standard?

1 reference

12 December 2020

Gabapentin's effects on hot flashes and hypothermia

1 reference

12 December 2020

How many stratification factors are "too many" to use in a randomization plan?

1 reference

12 December 2020

Whose opinion counts?

1 reference

12 December 2020

Identifiers

DOI

10.1200/JCO.2009.24.5647

1 reference

28 July 2017

1 reference

28 July 2017

1 reference